| 000 | 01556 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513082411.0 | ||
| 264 | 0 | _c19930621 | |
| 008 | 199306s 0 0 eng d | ||
| 022 | _a0364-5134 | ||
| 024 | 7 |
_a10.1002/ana.410330520 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJanus, T J | |
| 245 | 0 | 0 |
_aUse of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. _h[electronic resource] |
| 260 |
_bAnnals of neurology _cMay 1993 |
||
| 300 |
_a540-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBrachytherapy |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDeoxyglucose _xanalogs & derivatives |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorine Radioisotopes |
| 650 | 0 | 4 | _aFluorodeoxyglucose F18 |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRadiotherapy _xmethods |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aStereotaxic Techniques |
| 650 | 0 | 4 | _aTomography, Emission-Computed |
| 700 | 1 | _aKim, E E | |
| 700 | 1 | _aTilbury, R | |
| 700 | 1 | _aBruner, J M | |
| 700 | 1 | _aYung, W K | |
| 773 | 0 |
_tAnnals of neurology _gvol. 33 _gno. 5 _gp. 540-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ana.410330520 _zAvailable from publisher's website |
| 999 |
_c8498101 _d8498101 |
||